Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) today announced that it has entered into an agreement with Biotechnology Value Fund, L.P. ("BVF") ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE